Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

MSK physician-scientists Dr. Viviane Tabar and Dr. Lorenz Studer have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Reducing hair loss with scalp cooling Scalp cooling is a way to reduce hair loss while you’re getting chemo to treat solid tumors. Solid tumors are cancers that are not leukemia or lymphoma. Scalp ...

If you have questions or concerns, contact your healthcare provider. A member of your care team will answer Monday through Friday from 9 a.m. to 5 p.m. Outside those hours, you can leave a message or ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...

MSK’s screening guidelines for prostate cancer Talk with your healthcare provider about your risk for prostate cancer and when screening is right for you. If you decide to have prostate cancer ...

There are more than 125 different types of brain cancer. Most brain tumors fall into one of two categories: high grade (rapidly growing) or low grade (slow growing). At Memorial Sloan Kettering, we ...

The goal of the NCI Small Cell Lung Cancer Consortium is to accelerate progress against this deadly disease.

Memorial Sloan Kettering (MSK) has a special program for people who have benign (not cancer) pancreatic cysts or precancerous lesions. Our Pancreatic Cyst Surveillance Program is among the largest of ...